...
首页> 外文期刊>Histopathology: Official Journal of the British Division of the International Academy of Pathology >Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
【24h】

Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?

机译:CSF1过表达或重排是否影响膝关节的腱鞘细胞瘤中的生物行为?

获取原文
获取原文并翻译 | 示例
           

摘要

Aims Localised- and diffuse-type tenosynovial giant cell tumours (TGCT) are regarded as different clinical and radiological TGCT types. However, genetically and histopathologically they seem indistinguishable. We aimed to correlate CSF1 expression and CSF1 rearrangement with the biological behaviour of different TGCT-types with clinical outcome (recurrence). Methods and results Along a continuum of extremes, therapy-naive knee TGCT patients with 3-year follow-up, mean age 43 (range = 6-71) years and 56% females were selected. Nine localised (two recurrences), 16 diffuse-type (nine recurrences) and four synovitis as control were included. Rearrangement of the CSF1 locus was evaluated with split-apart fluorescence in-situ hybridisation (FISH) probes. Regions were selected to score after identifying CSF1-expressing regions, using mRNA ISH with the help of digital correlative microscopy. CSF1 rearrangement was considered positive in samples containing 2 split signals/100 nuclei. Irrespective of TGCT-subtype, all cases showed CSF1 expression and in 76% CSF1 rearrangement was detected. Quantification of CSF1-expressing cells was not informative, due to the extensive intratumour heterogeneity. Of the four synovitis cases, two also showed CSF1 expression without CSF1 rearrangement. No correlation between CSF1 expression or rearrangement with clinical subtype and local recurrence was detected. Both localised and diffuse TGCT cases showed a scattered distribution in the tissue of CSF1-expressing cells. Conclusion In diagnosing TGCT, CSF1 mRNA-ISH, in combination with CSF1 split-apart FISH using digital correlative microscopy, is an auxiliary diagnostic tool to identify rarely occurring neoplastic cells. This combined approach allowed us to detect CSF1 rearrangement in 76% of the TGCT cases. Neither CSF1 expression nor presence of CSF1 rearrangement could be associated with the difference in biological behaviour of TGCT.
机译:旨在鉴定 - 和弥漫性型腱鞘细胞肿瘤(TGCT)被认为是不同的临床和放射学TGCT类型。然而,遗传和组织病理学上它们看起来难以区分。我们的目标是将CSF1表达和CSF1重排与具有临床结果(复发)的不同TGCT系的生物学行为。方法和结果沿着极端连续体,治疗 - 天真的膝关节TGCT患者> 3年随访,平均43岁(范围= 6-71)岁,56%的女性被选中。包括九九局部(两种复发),16种弥漫型(九次复发)和四个滑膜炎作为对照。通过分开的荧光原位杂交(鱼类)探针评估CSF1基因座的重排。在用数字相关显微镜的帮助下,使用mRNA ISH鉴定CSF1表达区域后,选择区分。 CSF1重排被认为是含有&gt的样品中的阳性.2个分裂信号/ 100个核。无论TGCT-亚型如何,所有病例都显示出CSF1表达,检测到76%的CSF1重排。由于广泛的肠胃内,CSF1表达细胞的定量不是信息性的。在四种滑膜病例中,两种也显示出CSF1表达,没有CSF1重排。没有检测CSF1表达或与临床亚型和局部复发的重排之间的相关性。局部和扩散TGCT病例均显示CSF1表达细胞组织中的散射分布。结论在诊断TGCT中,CSF1 mRNA-ISH与使用数字相关显微镜的CSF1分裂鱼类组合,是辅助诊断工具,用于识别很少发生的肿瘤细胞。这种综合方法使我们能够在TGCT案例的76%中检测CSF1重排。 CSF1表达和CSF1重排的存在都没有与TGCT的生物学行为的差异相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号